These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

749 related items for PubMed ID: 17470580

  • 1. First-trimester ultrasonographic screening for trisomy 21 using fetal nuchal translucency and nasal bone.
    Sepulveda W, Wong AE, Dezerega V.
    Obstet Gynecol; 2007 May; 109(5):1040-5. PubMed ID: 17470580
    [Abstract] [Full Text] [Related]

  • 2. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening.
    Nicolaides KH, Spencer K, Avgidou K, Faiola S, Falcon O.
    Ultrasound Obstet Gynecol; 2005 Mar; 25(3):221-6. PubMed ID: 15736186
    [Abstract] [Full Text] [Related]

  • 3. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
    Falcon O, Auer M, Gerovassili A, Spencer K, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509
    [Abstract] [Full Text] [Related]

  • 4. Nuchal translucency and nasal bone for trisomy 21 screening: single center experience.
    Monni G, Zoppi MA, Ibba RM, Floris M, Manca F, Axiana C.
    Croat Med J; 2005 Oct; 46(5):786-91. PubMed ID: 16158472
    [Abstract] [Full Text] [Related]

  • 5. If nuchal translucency screening is combined with first-trimester serum screening the need for fetal karyotyping decreases.
    Marsk A, Grunewald C, Saltvedt S, Valentin L, Almström H.
    Acta Obstet Gynecol Scand; 2006 Oct; 85(5):534-8. PubMed ID: 16752230
    [Abstract] [Full Text] [Related]

  • 6. Sonographic screening for trisomy 13 at 11 to 13(+6) weeks of gestation.
    Papageorghiou AT, Avgidou K, Spencer K, Nix B, Nicolaides KH.
    Am J Obstet Gynecol; 2006 Feb; 194(2):397-401. PubMed ID: 16458636
    [Abstract] [Full Text] [Related]

  • 7. [Study on several ultrasound markers combined maternal serum biochemical markers to screen fetal chromosomal aneuploidy at 11 to 13(+)6 weeks of gestation].
    Chen X, Chang Y, Cui HY, Ren CC, Yu BY.
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):815-8. PubMed ID: 24444556
    [Abstract] [Full Text] [Related]

  • 8. Fetal nasal bone in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation.
    Kagan KO, Cicero S, Staboulidou I, Wright D, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2009 Mar; 33(3):259-64. PubMed ID: 19248005
    [Abstract] [Full Text] [Related]

  • 9. The utility of detailed first trimester ultrasound examination in abnormal fetal nuchal translucency.
    Bronshtein M, Zimmer EZ, Blazer S.
    Prenat Diagn; 2008 Nov; 28(11):1037-41. PubMed ID: 18925580
    [Abstract] [Full Text] [Related]

  • 10. Second-trimester prenatal screening for trisomy 21 using biochemical markers: a 7-year experience in one cytogenetic laboratory.
    Marical H, Douet-Guilbert N, Bages K, Collet M, Le Bris MJ, Morel F, De Braekeleer M.
    Prenat Diagn; 2006 Apr; 26(4):308-12. PubMed ID: 16491510
    [Abstract] [Full Text] [Related]

  • 11. First-trimester ductus venosus, nasal bones, and Down syndrome in a high-risk population.
    Prefumo F, Sethna F, Sairam S, Bhide A, Thilaganathan B.
    Obstet Gynecol; 2005 Jun; 105(6):1348-54. PubMed ID: 15932828
    [Abstract] [Full Text] [Related]

  • 12. Screening for trisomy 18 by maternal age, fetal nuchal translucency, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Kagan KO, Wright D, Maiz N, Pandeva I, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2008 Sep; 32(4):488-92. PubMed ID: 18726925
    [Abstract] [Full Text] [Related]

  • 13. First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
    Breathnach FM, Malone FD, Lambert-Messerlian G, Cuckle HS, Porter TF, Nyberg DA, Comstock CH, Saade GR, Berkowitz RL, Klugman S, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Tripp T, Bianchi DW, D'Alton ME, First and Second Trimester Evaluation of Risk (FASTER) Research Consortium.
    Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613
    [Abstract] [Full Text] [Related]

  • 14. Association of fetal choroid plexus cysts with trisomy 18 in a population previously screened by nuchal translucency thickness measurement.
    Cheng PJ, Shaw SW, Soong YK.
    J Soc Gynecol Investig; 2006 May; 13(4):280-4. PubMed ID: 16697944
    [Abstract] [Full Text] [Related]

  • 15. Evidence-based obstetric ethics and informed decision-making by pregnant women about invasive diagnosis after first-trimester assessment of risk for trisomy 21.
    Nicolaides KH, Chervenak FA, McCullough LB, Avgidou K, Papageorghiou A.
    Am J Obstet Gynecol; 2005 Aug; 193(2):322-6. PubMed ID: 16098850
    [Abstract] [Full Text] [Related]

  • 16. First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics.
    Kagan KO, Wright D, Spencer K, Molina FS, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2008 May; 31(5):493-502. PubMed ID: 18432600
    [Abstract] [Full Text] [Related]

  • 17. Relation between increased fetal nuchal translucency thickness and chromosomal defects.
    Kagan KO, Avgidou K, Molina FS, Gajewska K, Nicolaides KH.
    Obstet Gynecol; 2006 Jan; 107(1):6-10. PubMed ID: 16394033
    [Abstract] [Full Text] [Related]

  • 18. [The prenatal detection of trisomy 13, 18, and 21: comparison of the advanced first trimester screening (AFS) with the first trimester screening according to Nicolaides].
    Hörmansdörfer C, Schmidt P, Hillemanns P, Scharf A.
    Z Geburtshilfe Neonatol; 2007 Dec; 211(6):243-9. PubMed ID: 18176905
    [Abstract] [Full Text] [Related]

  • 19. Nuchal translucency and nasal bone in first-trimester ultrasound screening for aneuploidy in multiple pregnancies.
    Sepulveda W, Wong AE, Casasbuenas A.
    Ultrasound Obstet Gynecol; 2009 Feb; 33(2):152-6. PubMed ID: 18985621
    [Abstract] [Full Text] [Related]

  • 20. Nuchal fold thickness, nasal bone absence or hypoplasia, ductus venosus reversed flow and tricuspid valve regurgitation in screening for trisomies 21, 18 and 13 in the early second trimester.
    Geipel A, Willruth A, Vieten J, Gembruch U, Berg C.
    Ultrasound Obstet Gynecol; 2010 May; 35(5):535-9. PubMed ID: 20183867
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.